Correlation Between Capricor Therapeutics and Alto Neuroscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and Alto Neuroscience,, you can compare the effects of market volatilities on Capricor Therapeutics and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and Alto Neuroscience,.

Diversification Opportunities for Capricor Therapeutics and Alto Neuroscience,

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Capricor and Alto is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and Alto Neuroscience, go up and down completely randomly.

Pair Corralation between Capricor Therapeutics and Alto Neuroscience,

Given the investment horizon of 90 days Capricor Therapeutics is expected to under-perform the Alto Neuroscience,. But the stock apears to be less risky and, when comparing its historical volatility, Capricor Therapeutics is 1.23 times less risky than Alto Neuroscience,. The stock trades about -0.14 of its potential returns per unit of risk. The Alto Neuroscience, is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  401.00  in Alto Neuroscience, on August 30, 2024 and sell it today you would earn a total of  27.00  from holding Alto Neuroscience, or generate 6.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Capricor Therapeutics  vs.  Alto Neuroscience,

 Performance 
       Timeline  
Capricor Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Alto Neuroscience, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alto Neuroscience, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Capricor Therapeutics and Alto Neuroscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capricor Therapeutics and Alto Neuroscience,

The main advantage of trading using opposite Capricor Therapeutics and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.
The idea behind Capricor Therapeutics and Alto Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios